Total Valuation
Tonix Pharma has a market cap or net worth of €186.76M. The enterprise value is €37.31.
Market Cap€186.76M
Enterprise Value€37.31
Share Statistics
Tonix Pharma has 17,151,024 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,151,024
Owned by Insiders0.22%
Owned by Institutions8.50%
Financial Efficiency
Tonix Pharma’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -51.00%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-51.00%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee92.30K
Profits Per Employee-873.39K
Employee Count142
Asset Turnover0.05
Inventory Turnover1.42
Valuation Ratios
The current PE Ratio of Tonix Pharma is ―. Tonix Pharma’s PEG ratio is 0.01.
PE Ratio―
PS Ratio10.14
PB Ratio0.54
Price to Fair Value0.54
Price to FCF-1.29
Price to Operating Cash Flow-1.35
PEG Ratio0.01
Income Statement
In the last 12 months, Tonix Pharma had revenue of 13.11M and earned -124.02M in profits. Earnings per share was -14.57.
Revenue13.11M
Gross Profit4.54M
Operating Income-125.70M
Pretax Income-124.02M
Net Income-124.02M
EBITDA-122.01M
Earnings Per Share (EPS)-14.57
Cash Flow
In the last 12 months, operating cash flow was -154.72M and capital expenditures -5.17M, giving a free cash flow of -159.89M billion.
Operating Cash Flow-154.72M
Free Cash Flow-159.89M
Free Cash Flow per Share-9.32
Dividends & Yields
Tonix Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change-66.84%
50-Day Moving Average10.04
200-Day Moving Average12.02
Relative Strength Index (RSI)57.57
Average Volume (3m)5.00
Important Dates
Tonix Pharma upcoming earnings date is Nov 9, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
Tonix Pharma as a current ratio of 7.42, with Debt / Equity ratio of 0.57%
Current Ratio7.42
Quick Ratio7.23
Debt to Market Cap0.00
Net Debt to EBITDA1.69
Interest Coverage Ratio-1.41K
Taxes
In the past 12 months, Tonix Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tonix Pharma EV to EBITDA ratio is 0.60, with an EV/FCF ratio of 0.71.
EV to Sales-5.60
EV to EBITDA0.60
EV to Free Cash Flow0.71
EV to Operating Cash Flow0.73
Balance Sheet
Tonix Pharma has €176.23M in cash and marketable securities with €1.27M in debt, giving a net cash position of €174.96M billion.
Cash & Marketable Securities€176.23M
Total Debt€1.27M
Net Cash€174.96M
Net Cash Per Share€10.20
Tangible Book Value Per Share€28.79
Margins
Gross margin is 80.25%, with operating margin of -959.05%, and net profit margin of -946.22%.
Gross Margin80.25%
Operating Margin-959.05%
Pretax Margin-946.22%
Net Profit Margin-946.22%
EBITDA Margin-930.85%
EBIT Margin-945.54%
Analyst Forecast
The average price target for Tonix Pharma is €32.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€32.82
Price Target Upside267.52% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast169.54%
EPS Growth Forecast98.84%